Your browser doesn't support javascript.
loading
PD-L1 overexpression correlates with JAK2-V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms.
Milosevic Feenstra, Jelena D; Jäger, Roland; Schischlik, Fiorella; Ivanov, Daniel; Eisenwort, Gregor; Rumi, Elisa; Schuster, Michael; Gisslinger, Bettina; Machherndl-Spandl, Sigrid; Bettelheim, Peter; Krauth, Maria-Theresa; Keil, Felix; Bock, Christoph; Cazzola, Mario; Gisslinger, Heinz; Kralovics, Robert; Valent, Peter.
Afiliación
  • Milosevic Feenstra JD; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Jäger R; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
  • Schischlik F; Cancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
  • Ivanov D; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
  • Eisenwort G; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Rumi E; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
  • Schuster M; Department of Molecular Medicine, University of Pavia, Pavia, Italy.
  • Gisslinger B; Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Machherndl-Spandl S; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Bettelheim P; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
  • Krauth MT; Department of Haematology, Internal Oncology and Stem Cell Transplantation, Ordensklinikum Linz Elisabethinen Hospital, Linz, Austria.
  • Keil F; Department of Haematology, Internal Oncology and Stem Cell Transplantation, Ordensklinikum Linz Elisabethinen Hospital, Linz, Austria.
  • Bock C; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Cazzola M; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
  • Gisslinger H; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Kralovics R; 3rd Medical Department, Hematology & Oncology, Hanuschkrankenhaus, Vienna, Austria.
  • Valent P; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Am J Hematol ; 97(4): 390-400, 2022 04.
Article en En | MEDLINE | ID: mdl-35015307
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Policitemia Vera / Disomía Uniparental / Antígeno B7-H1 / Trastornos Mieloproliferativos Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Am J Hematol Año: 2022 Tipo del documento: Article País de afiliación: Austria
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Policitemia Vera / Disomía Uniparental / Antígeno B7-H1 / Trastornos Mieloproliferativos Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Am J Hematol Año: 2022 Tipo del documento: Article País de afiliación: Austria